London-based Smith & Nephew plc raised its 2019 revenue prospects, buoyed by strong second-quarter sales of sports medicine products in the U.S. and a spike in sales in China. Total revenue for the quarter hit $1.3 billion, up 3.1% from the same period a year ago, putting the company at $2.5 billion at the half-year mark and 1.8% above the 2018 six-month total of $2.4 billion, on a reported basis. Underlying growth for the first six months was 3.9%.